BRM
TMO icon

Boston Research & Management’s Thermo Fisher Scientific TMO Stock Holding History

Boston Research & Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.5M Buy
10,974
+160
+1% +$76.8K 1.22% 36
2026
Q1 		$5.32M Buy
10,814
+235
+2% +$128K 1.26% 35
2025
Q4 		$6.13M Sell
10,579
-392
-4% -$222K 1.41% 27
2025
Q3 		$5.32M Buy
10,971
+17
+0.2% +$7.91K 1.17% 35
2025
Q2 		$4.44M Buy
10,954
+1,639
+18% +$685K 1.06% 44
2025
Q1 		$4.63M Buy
9,315
+17
+0.2% +$9.21K 1.15% 39
2024
Q4 		$4.84M Buy
9,298
+7
+0.1% +$3.85K 1.19% 40
2024
Q3 		$5.75M Buy
9,291
+228
+3% +$135K 1.35% 31
2024
Q2 		$5.01M Buy
9,063
+84
+0.9% +$48.1K 1.27% 34
2024
Q1 		$5.22M Buy
8,979
+107
+1% +$60K 1.29% 36
2023
Q4 		$4.71M Buy
8,872
+434
+5% +$210K 1.25% 36
2023
Q3 		$4.27M Buy
8,438
+138
+2% +$73.5K 1.26% 35
2023
Q2 		$4.33M Buy
8,300
+117
+1% +$63.1K 1.23% 39
2023
Q1 		$4.72M Buy
8,183
+60
+0.7% +$33.8K 1.41% 29
2022
Q4 		$4.47M Buy
8,123
+133
+2% +$70.5K 1.38% 31
2022
Q3 		$4.05M Buy
7,990
+130
+2% +$72.8K 1.38% 31
2022
Q2 		$4.27M Buy
7,860
+382
+5% +$210K 1.38% 32
2022
Q1 		$4.42M Buy
7,478
+1,217
+19% +$699K 1.28% 38
2021
Q4 		$4.18M Hold
6,261
– – 1.14% 37
2021
Q3 		$3.58M Buy
6,261
+43
+0.7% +$23.6K 1.07% 40
2021
Q2 		$3.14M Buy
6,218
+1,631
+36% +$770K 0.95% 44
2021
Q1 		$2.09M Buy
4,587
+1,632
+55% +$779K 0.67% 54
2020
Q4 		$1.38M Buy
2,955
+423
+17% +$198K 0.48% 60
2020
Q3 		$1.12M Buy
2,532
+15
+0.6% +$6.2K 0.44% 58
2020
Q2 		$912K Buy
+2,517
New +$844K 0.38% 62

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Boston Research & Management's TMO Position: Q2 2026 in Review

Boston Research & Management increased its Thermo Fisher Scientific (TMO) stake by 1.5% in Q2 2026, buying an estimated $76.8K and bringing the position to 10,974 shares worth $5.5M. The position accounts for 1.22% of the portfolio, ranked #36.

Boston Research & Management first reported a position in TMO in Q2 2020 and has held it in 25 quarters since. The position peaked at $6.13M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Boston Research & Management held 10,974 shares of Thermo Fisher Scientific worth $5.5M as of Q2 2026.
  • Boston Research & Management bought 160 Thermo Fisher Scientific shares in Q2 2026, an estimated $76.8K.
  • Thermo Fisher Scientific made up 1.22% of Boston Research & Management's portfolio in Q2 2026, its #36 holding.
  • Boston Research & Management first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 25 quarters since.
  • Boston Research & Management's Thermo Fisher Scientific position peaked at $6.13M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Boston Research & Management's 13F filing for Q2 2026, filed 11 Aug 2026.